OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Thrombospondin-1 promotes tumor progression in cutaneous T-cell lymphoma via CD47
Hiroaki Kamijo, Tomomitsu Miyagaki, Naomi Shishido, et al.
Leukemia (2019) Vol. 34, Iss. 3, pp. 845-856
Closed Access | Times Cited: 56

Showing 1-25 of 56 citing articles:

The MYC oncogene — the grand orchestrator of cancer growth and immune evasion
Renumathy Dhanasekaran, Anja Deutzmann, Wadie D. Mahauad‐Fernandez, et al.
Nature Reviews Clinical Oncology (2021) Vol. 19, Iss. 1, pp. 23-36
Open Access | Times Cited: 552

Functions of Thrombospondin-1 in the Tumor Microenvironment
Sukhbir Kaur, Steven M. Bronson, Dipasmita Pal-Nath, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 9, pp. 4570-4570
Open Access | Times Cited: 110

Tumor-derived exosomal components: the multifaceted roles and mechanisms in breast cancer metastasis
Yufang Tan, Xiao Luo, Wenchang Lv, et al.
Cell Death and Disease (2021) Vol. 12, Iss. 6
Open Access | Times Cited: 68

Role of CD47 in tumor immunity: a potential target for combination therapy
Jing Huang, Fangkun Liu, Chenglong Li, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 38

Tolerating CD47
Jeffrey S. Isenberg, Enrique Montero
Clinical and Translational Medicine (2024) Vol. 14, Iss. 2
Open Access | Times Cited: 10

Upregulation of THBS1 is Related to Immunity and Chemotherapy Resistance in Gastric Cancer
Xiuyuan Zhang, Tingting Huang, Yiming Li, et al.
International Journal of General Medicine (2021) Vol. Volume 14, pp. 4945-4957
Open Access | Times Cited: 44

CD47: Beyond an immune checkpoint in cancer treatment
Huiting Bian, Yiwen Shen, Yu‐Dong Zhou, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2022) Vol. 1877, Iss. 5, pp. 188771-188771
Closed Access | Times Cited: 30

Novel targeted therapies of T cell lymphomas
Katarzyna Iżykowska, Karolina Rassek, Dorota Korsak, et al.
Journal of Hematology & Oncology (2020) Vol. 13, Iss. 1
Open Access | Times Cited: 48

Large-scale circular RNA deregulation in T-ALL: unlocking unique ectopic expression of molecular subtypes
Alessia Buratin, Maddalena Paganin, Enrico Gaffo, et al.
Blood Advances (2020) Vol. 4, Iss. 23, pp. 5902-5914
Open Access | Times Cited: 41

Cancer Therapy Targeting CD47/SIRPα
Nazlı Dizman, Elizabeth I. Buchbinder
Cancers (2021) Vol. 13, Iss. 24, pp. 6229-6229
Open Access | Times Cited: 35

Improving cancer immunotherapy via co-delivering checkpoint blockade and thrombospondin-1 downregulator
Qingqing Xiao, Xiaotong Li, Chang Liu, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 13, Iss. 8, pp. 3503-3517
Open Access | Times Cited: 27

MYC in liver cancer: mechanisms and targeted therapy opportunities
Furong Liu, Zhibin Liao, Zhanguo Zhang
Oncogene (2023) Vol. 42, Iss. 45, pp. 3303-3318
Closed Access | Times Cited: 14

Cell autonomous functions of CD47 in regulating cellular plasticity and metabolic plasticity
Ruhi Polara, Raja Ganesan, Stuart M. Pitson, et al.
Cell Death and Differentiation (2024) Vol. 31, Iss. 10, pp. 1255-1266
Open Access | Times Cited: 5

Mechanism of THBS1 Regulation of MDCK Cell Proliferation and Apoptosis Through TGF-β/Smad Signalling
Rui Li, Fan Zhang, Lijin Wang, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 1, pp. 395-395
Open Access

NEW DIAGNOSTIC BIOMARKERS FOR EARLY STAGES OF CUTANEOUS T-CELL LYMPHOMA
Olga A. Gafurova, Oleg Danilik, O.V. Anufrieva, et al.
Molekulyarnaya Meditsina (Molecular medicine) (2025), pp. 18-23
Closed Access

Targeting myeloid cells for hematological malignancies: the present and future
Zhenpeng Guan, Zhengqi Zhang, Kaiyan Wang, et al.
Biomarker Research (2025) Vol. 13, Iss. 1
Open Access

CD47 promotes the proliferation and migration of adamantinomatous craniopharyngioma cells by activating the MAPK/ERK pathway, and CD47 blockade facilitates microglia‐mediated phagocytosis
Huarong Zhang, Chaohu Wang, Jun Fan, et al.
Neuropathology and Applied Neurobiology (2022) Vol. 48, Iss. 4
Closed Access | Times Cited: 21

THBS1 promotes angiogenesis and accelerates ESCC malignant progression by the HIF‐1/VEGF signaling pathway
Xiao Zhou, Qiaoxi Xia, Mantong Chen, et al.
Cell Biology International (2024) Vol. 48, Iss. 3, pp. 311-324
Closed Access | Times Cited: 4

Advances in Novel Systemic Therapies for the Management of Cutaneous T Cell Lymphoma (CTCL)
Katherine Case, Pamela B. Allen
Current Hematologic Malignancy Reports (2025) Vol. 20, Iss. 1
Closed Access

Optimizing antibody stability and efficacy in CD47- SIRPα inhibition via computational approaches
Kapil Laddha, M. Elizabeth Sobhia
Molecular Diversity (2025)
Closed Access

Exosomal CCT3 as a biomarker for diagnosis and immune therapy response in patients diagnosed with hepatocellular carcinoma
Tiange Liu, Yanyan Cui, Yiben Ouyang, et al.
Digestive and Liver Disease (2025)
Closed Access

Regulators at Every Step—How microRNAs Drive Tumor Cell Invasiveness and Metastasis
Tomasz M. Grzywa, Klaudia Klicka, Paweł Włodarski
Cancers (2020) Vol. 12, Iss. 12, pp. 3709-3709
Open Access | Times Cited: 32

Page 1 - Next Page

Scroll to top